SCHEMBL6468113

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL6889350	0.91	AR (0.69)	ARCCR9GRIA2GRIA4PTGDR2
	SCHEMBL6891066	0.89	AR (0.66)	ARCCR9GRIA2GRIA4PTGDR2
	SCHEMBL6888241	0.89	AR (0.69)	ARPTGDR2EGLN1
	SCHEMBL6469801	0.89	AR (0.66)	ARPTGDR2EGLN1FNTAFNTB
	SCHEMBL6464451	0.85	AR (0.80)	ARPTGDR2
	SCHEMBL6468062	0.83	AR (1.00)	ARGRIA2GRIA4PTGDR2KDM4E
	SCHEMBL6465983	0.82	AR (0.66)	AR
	SCHEMBL6468893	0.82	AR (0.75)	ARKDM4EALDH1A1
	SCHEMBL6466407	0.82	AR (0.75)	ARPTGDR2
	SCHEMBL6469502	0.82	AR (0.75)	AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.